The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Tumor Microenvironment Responsive Nanogel for the Combinatorial Antitumor Effect of Chemotherapy and Immunotherapy
Abstract
A biomimetic nanogel with tumor microenvironment responsive property is developed for the combinatorial antitumor effects of chemotherapy and immunotherapy. Nanogels are formulated with hydroxypropyl-β-cyclodextrin acrylate and two opposite charged chitosan derivatives for entrapping anticancer drug paclitaxel and precisely controlling the pH responsive capability, respectively. The nanogel supported erythrocyte membrane can achieve "nanosponge" property for delivering immunotherapeutic agent interleukin-2 without reducing the bioactivity. By responsively releasing drugs in tumor microenvironment, the nanogels significantly enhanced antitumor activity with improved drug penetration, induction of calreticulin exposure, and increased antitumor immunity. The tumor microenvironment is remodeled by the combination of these drugs in low dosage, as evidenced by the promoted infiltration of immune effector cells and reduction of immunosuppressive factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
Hu, C.-M. J., Zhang, L., Aryal, S., Cheung, C., Fang, R. H., & Zhang, L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106634108 · Cited by 2,433
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164
Regulatory T cells in cancer immunotherapy
Tanaka, A., & Sakaguchi, S. (2017) · Cell Research · doi:10.1038/cr.2016.151 · Cited by 1,860
Cyclodextrins and their pharmaceutical applications
LOFTSSON, T., & DUCHENE, D. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.10.044 · Cited by 1,764
Nanotechnology in Drug Delivery and Tissue Engineering: From Discovery to Applications
Shi, J., Votruba, A. R., Farokhzad, O. C., & Langer, R. (2010) · Nano Letters · doi:10.1021/nl102184c · Cited by 1,612
Immunological effects of conventional chemotherapy and targeted anticancer agents
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.10.012 · Cited by 1,530
Nanogels as Pharmaceutical Carriers: Finite Networks of Infinite Capabilities
Kabanov, A. V., & Vinogradov, S. V. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200900441 · Cited by 1,313
Malek, T. R. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090357 · Cited by 1,079
Chen, S.-C., Wu, Y.-C., Mi, F.-L., Lin, Y.-H., Yu, L.-C., & Sung, H.-W. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.02.002 · Cited by 935
Zitvogel, L., Galluzzi, L., Smyth, M. J., & Kroemer, G. (2013) · Immunity · doi:10.1016/j.immuni.2013.06.014 · Cited by 870
A biomimetic nanosponge that absorbs pore-forming toxins
Hu, C.-M. J., Fang, R. H., Copp, J., Luk, B. T., & Zhang, L. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.54 · Cited by 751
2-Hydroxypropyl-β-cyclodextrin (HP-β-CD): A toxicology review
Gould, S., & Scott, R. C. (2005) · Food and Chemical Toxicology · doi:10.1016/j.fct.2005.03.007 · Cited by 746
Regulatory T cells in cancer immunotherapy
Nishikawa, H., & Sakaguchi, S. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.12.005 · Cited by 705
Immunotherapy and chemotherapy — a practical partnership
Lake, R. A., & Robinson, B. W. S. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1613 · Cited by 646
Rao, L., Bu, L., Xu, J., Cai, B., Yu, G., Yu, X., He, Z., Huang, Q., Li, A., Guo, S., et al. (2015) · Small · doi:10.1002/smll.201502388 · Cited by 513
Park, J., Wrzesinski, S. H., Stern, E., Look, M., Criscione, J., Ragheb, R., Jay, S. M., Demento, S. L., Agawu, A., Licona Limon, P., et al. (2012) · Nature Materials · doi:10.1038/nmat3355 · Cited by 494
Cell or Cell Membrane-Based Drug Delivery Systems
Tan, S., Wu, T., Zhang, D., & Zhang, Z. (2015) · Theranostics · doi:10.7150/thno.11852 · Cited by 466
Self-citationGuo, Y., Wang, D., Song, Q., Wu, T., Zhuang, X., Bao, Y., Kong, M., Qi, Y., Tan, S., & Zhang, Z. (2015) · ACS Nano · doi:10.1021/acsnano.5b01042 · Cited by 413
Self-citationStimuli‐Responsive Materials for Controlled Release of Theranostic Agents
Wang, Y., Shim, M. S., Levinson, N. S., Sung, H., & Xia, Y. (2014) · Advanced Functional Materials · doi:10.1002/adfm.201400279 · Cited by 378
Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles
Luk, B. T., Jack Hu, C.-M., Fang, R. H., Dehaini, D., Carpenter, C., Gao, W., & Zhang, L. (2013) · Nanoscale · doi:10.1039/c3nr06371b · Cited by 375
Liu, W. M., Fowler, D. W., Smith, P., & Dalgleish, A. G. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605465 · Cited by 356
Inflammation‐Triggered Cancer Immunotherapy by Programmed Delivery of CpG and Anti‐PD1 Antibody
Wang, C., Sun, W., Wright, G., Wang, A. Z., & Gu, Z. (2016) · Advanced Materials · doi:10.1002/adma.201506312 · Cited by 344
Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance
Creixell, M., & Peppas, N. A. (2012) · Nano Today · doi:10.1016/j.nantod.2012.06.013 · Cited by 331
Xu, Z., Wang, Y., Zhang, L., & Huang, L. (2014) · ACS Nano · doi:10.1021/nn500216y · Cited by 284
The IL-2 cytokine family in cancer immunotherapy
Sim, G. C., & Radvanyi, L. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.07.018 · Cited by 278
Zhao, X., Yang, K., Zhao, R., Ji, T., Wang, X., Yang, X., Zhang, Y., Cheng, K., Liu, S., Hao, J., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.032 · Cited by 256
The Role of the Mediators of Inflammation in Cancer Development
Fernandes, J. V., Cobucci, R. N. O., Jatobá, C. A. N., de Medeiros Fernandes, T. A. A., de Azevedo, J. W. V., & de Araújo, J. M. G. (2015) · Pathology & Oncology Research · doi:10.1007/s12253-015-9913-z · Cited by 251
Xu, X., Wu, J., Liu, Y., Yu, M., Zhao, L., Zhu, X., Bhasin, S., Li, Q., Ha, E., Shi, J., et al. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201601273 · Cited by 250
Therapeutic approaches to enhance natural killer cell cytotoxicity against cancer: the force awakens
Childs, R. W., & Carlsten, M. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4506 · Cited by 236
Co-delivery of chemotherapeutics and proteins for synergistic therapy
He, C., Tang, Z., Tian, H., & Chen, X. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.021 · Cited by 231
Wu, W., Shen, J., Banerjee, P., & Zhou, S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.07.061 · Cited by 222
Su, J., Sun, H., Meng, Q., Yin, Q., Tang, S., Zhang, P., Chen, Y., Zhang, Z., Yu, H., & Li, Y. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201504780 · Cited by 220
Self-citationUltrasensitive pH Triggered Charge/Size Dual-Rebound Gene Delivery System
Guan, X., Guo, Z., Lin, L., Chen, J., Tian, H., & Chen, X. (2016) · Nano Letters · doi:10.1021/acs.nanolett.6b02536 · Cited by 201
An immunostimulatory dual-functional nanocarrier that improves cancer immunochemotherapy
Chen, Y., Xia, R., Huang, Y., Zhao, W., Li, J., Zhang, X., Wang, P., Venkataramanan, R., Fan, J., Xie, W., et al. (2016) · Nature Communications · doi:10.1038/ncomms13443 · Cited by 190
Shen, S., Li, H.-J., Chen, K.-G., Wang, Y.-C., Yang, X.-Z., Lian, Z.-X., Du, J.-Z., & Wang, J. (2017) · Nano Letters · doi:10.1021/acs.nanolett.7b01193 · Cited by 186
Cyclodextrin-based nanogels for pharmaceutical and biomedical applications
Moya-Ortega, M. D., Alvarez-Lorenzo, C., Concheiro, A., & Loftsson, T. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.02.038 · Cited by 185
Konno, T., Watanabe, J., & Ishihara, K. (2003) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.10481 · Cited by 180
Hu, Q., Sun, W., Lu, Y., Bomba, H. N., Ye, Y., Jiang, T., Isaacson, A. J., & Gu, Z. (2016) · Nano Letters · doi:10.1021/acs.nanolett.5b04343 · Cited by 162
Chitosan- g -TPGS Nanoparticles for Anticancer Drug Delivery and Overcoming Multidrug Resistance
Guo, Y., Chu, M., Tan, S., Zhao, S., Liu, H., Otieno, B. O., Yang, X., Xu, C., & Zhang, Z. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400514t · Cited by 156
Self-citationChemotherapy and immunotherapy: mapping the road ahead
Cook, A., Lesterhuis, W. J., Nowak, A. K., & Lake, R. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.12.003 · Cited by 138
Zhang, J., Zhu, X. D., Jin, Y., Shan, W., & Huang, Y. (2014) · Molecular Pharmaceutics · doi:10.1021/mp400685v · Cited by 136
Vicari, A. P., Luu, R., Zhang, N., Patel, S., Makinen, S. R., Hanson, D. C., Weeratna, R. D., & Krieg, A. Μ. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0586-2 · Cited by 130
Combinatorial prospects of nano-targeted chemoimmunotherapy
Silva, C. G. D., Rueda, F., Löwik, C. W. G. M., OSSENDORP, F. A., & Cruz, L. J. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.01.006 · Cited by 129
Surface‐exposed calreticulin in the interaction between dying cells and phagocytes
Martins, I., Kepp, O., Galluzzi, L., Senovilla, L., Schlemmer, F., Adjemian, S., Menger, L., Michaud, M., Zitvogel, L., & Kroemer, G. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05740.x · Cited by 123
Wu, X., He, C., Wu, Y., Chen, X., & Cheng, J. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201502742 · Cited by 115
Popat, A., Karmakar, S., Jambhrunkar, S., Xu, C., & Yu, C. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.03.005 · Cited by 110
Engineering red‐blood‐cell‐membrane–coated nanoparticles for broad biomedical applications
Gao, W., & Zhang, L. (2015) · AIChE Journal · doi:10.1002/aic.14735 · Cited by 105
Novel mechanism of synergistic effects of conventional chemotherapy and immune therapy of cancer
Ramakrishnan, R., & Gabrilovich, D. I. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1390-6 · Cited by 97
Wu, J., Tang, C., & Yin, C. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.10.012 · Cited by 92
Paclitaxel nanoparticle awakens immune system to fight against cancer
Tang, W., Yang, J., Yuan, Y., Zhao, Z., Lian, Z., & Liang, G. (2017) · Nanoscale · doi:10.1039/c6nr09895a · Cited by 47
A novel multi-drug metronomic chemotherapy significantly delays tumor growth in mice
Tagliamonte, M., Petrizzo, A., Napolitano, M., Luciano, A., Rea, D., Barbieri, A., Arra, C., Maiolino, P., Tornesello, M. L., Ciliberto, G., et al. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0812-1 · Cited by 22
Garg, A. D., Dudek-Perić, A. M., & Agostinis, P. (2015) · Oncoscience · doi:10.18632/oncoscience.228 · Cited by 3
Cited by
Cell Membrane Coating Nanotechnology
Fang, R. H., Kroll, A. V., Gao, W., & Zhang, L. (2018) · Advanced Materials · doi:10.1002/adma.201706759 · Cited by 1,885
Polymeric Nanoparticles for Drug Delivery
Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00705 · Cited by 1,155
Targeting drugs to tumours using cell membrane-coated nanoparticles
Fang, R. H., Gao, W., & Zhang, L. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00699-x · Cited by 980
Cancer nanomedicine for combination cancer immunotherapy
Nam, J., Son, S., Park, K. S., Zou, W., Shea, L. D., & Moon, J. J. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0108-1 · Cited by 940
Recent progress in drug delivery
Li, C., Wang, J., Wang, Y., Gao, H., Wei, G., Huang, Y., Yu, H., Gan, Y., Wang, Y., Mei, L., et al. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.08.003 · Cited by 818
Self-citation
Metadata
- Authors
- Song, Q., Yin, Y., Shang, L., Wu, T., Zhang, D., Kong, M., Zhao, Y., He, Y., Tan, S., Guo, Y., & Zhang, Z.
- Venue
- Nano Letters
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-09-05
- Volume
- 17
- Issue
- 10
- Pages
- 6366-6375
- ISSN
- 1530-6984 (ISSN-L)
- 1530-6992
- OpenAlex
- W2752897349
- Cited by
- 254
- References
- 53
- FWCI
- 8.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.